Dmitriy Zamarin, MD, PhD
Immunotherapy is slowly evolving in the gynecologic malignancies landscape and has moved beyond only having a role in ovarian cancer, according to Dmitriy Zamarin, MD, PhD.
on Treatment of Ovarian Cancer, Zamarin, a medical oncologist at Memorial Sloan Kettering Cancer Center, discussed the role of immunotherapy for patients with gynecologic malignancies.
OncLive: Beyond ovarian cancer, in what other gynecologic malignancies has immunotherapy shown potential?
Ovarian cancer is not the only cancer that we treat with immunotherapy. Immunotherapy has also been shown to be effective in endometrial cancer. We already have a very effective drug, pembrolizumab, approved for MSI-H endometrial cancers or for any MSI-H tumor. It could encompass some of the patients with ovarian cancer, but it is specific to the endometrial histology.
... to read the full story